This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AngioDynamics Inc (ANGO)

NASDAQ: Health Care

Company Cash Flow
May 2015 May 2014 May 2013 May 2012
Cash Flow From Operating Activities
Net Income (Loss) -3.27M 3.09M -612.00K 0.00
Operating Gains/Losses 0.00 0.00 705.00K 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 2.10M -14.86M 1.14M -2.50M
(Increase) Decrease in Inventories -6.15M -5.45M -1.91M -1.09M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -5.88M 7.25M -10.04M 6.67M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 0.00 0.00 0.00 0.00
Other Non-Cash Items 15.06M 4.00M 5.04M -46.00K
Net Cash From Continuing Operations 26.24M 25.28M 26.88M 11.50M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 26.24M 25.28M 26.88M 11.50M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 353.00K 16.99M 194.11M
Purchases of Property, Plant & Equipment -13.29M -13.21M -12.92M -2.49M
Acquisitions 0.00 -4.17M -24.47M -237.87M
Purchases of Short-Term Investments 0.00 -25.00K -5.13M -123.61M
Other Cash from Investing Activities 0.00 0.00 3.30M -6.50M
Cash Provided by Financing Activities
Net Cash From Investing Activities -13.29M -17.05M -22.24M -176.36M
Issuance of Debt 15.00M 146.41M 0.00 150.00M
Cash Used for Financing Activities
Issuance of Capital Stock 5.76M 2.44M 1.21M 3.37M
Repayment of Long-Term Debt -20.00M -146.25M -7.50M -6.55M
Repurchase of Capital Stock 0.00 0.00 0.00 -2.10M
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -11.22M -16.62M 0.00 -2.38M
Net Cash From Financing Activities -10.46M -14.02M -6.29M 142.34M
Effect of Exchange Rate Changes -198.00K 86.00K -65.00K 49.00K
Net Change in Cash & Cash Equivalents 2.29M -5.70M -1.71M -22.48M

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

ANGO AngioDynamics Inc

Chart of ANGO

Analysts Ratings for ANGO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 1 1 1
Hold 2 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

ANGO Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs